|
Education Courses “Prevalence and Prevention of Cardiomyophathy” |
|
|
|
It
is impossible to imagine the 21st century without collecting
exact statistical data on cardio-vascular diseases. In Georgia there are
no complete data on such sever
pathologies as ischemic heart disease (IHD), arterial hyperfengion (AH),
atherosclerosis; as well as there are no data on the development of their
complications, including sudden death, for rural, or urban; plain or
mountain regions. In developed countries strategies for prevention and
treatment of these conditions are elaborated to this or that degree Viral
diseases, including heart and liver ones, that today are the world
epidemic due to narcomania increase, may be the leading cause of mortality
and disablement in atherosclrerosis and (IHD) lethality. Besides, they
play an important role in the increase of the heart failure syndrome (HFS)
frequency among young and capable to world population. Thus, for the
diseases prognosis, it is very important to timely reveal and treat at an
early stage such viral heart and liver disease, and their associated
forms. Implamentation of appropriate high technologies in the clinical
practice will facilitate early. diagnosis of these conditions and
prevention of their complication development. Resulting
from rather complicated technical and economic situation in our country,
the Cardiomyopathy Program must include at least the minimal conditions,
necessary for primary prevention and development of therapeutic strategies
for above-mentioned pathologies. This Program is aimed at physician (both
beginners and experienced ones) continuous training and education, to
obtain adequate theoretical and practical knowledge. For this up-to-date
literature on the subject, and work with such patients at the clinical
departments will be implemented. The traines will be tought to fill
careful and complete case reports, carry out differential analysis, they
will received detailed information on relevant pharmaceutical
preparations. In
2003 the International Cardiomyophaty Society, and Cardiomyopathy and CIHD
Department, under the guidance of Acad. Nodar Kipshidze will held
mentioned below Education Courses at the National Center of Therapy and Clinical-Research Institute of Therapy. 1.
Cardiomyophaties – historic review; viral infections (i.e.
cardiomyotropic, hepatotropic, etc) cause cardio-vascular,
gastro-intestinal, and central nervous system pathologies; have the most
pronounced effect on the cardio-vascular system and the course of
associated and separate forms of viral infections. 2.
Modern classification of cardiomyopathies (Acad. N Kipshidze’s
classification, historic review of the cardiomyopathy classification),
their ethiopathogenic and pathophysiologic aspects. 3.
Main biochemical and energy exchange processes in healthy and
cardiomyopathy cardiac muscle (from embriogenesis till old-ages);
physiology of systemic and pulmonary circulations (in relation to
respiratory, central and other systems), and their pathophysiology in
patients with cardiomiopathy. 4.
Haematopoietic organs (short physiologic, biologic and biophysical
properties of blood, micro-and macromorpho functional aspects in primary
and secondary at cardiomyophaties). 5.
Immunization; NO, HLA markers; vitamins; microelement metabolism disorders
and paramagnetic shifts in cardiac muscle in primary and secondary
cardiomyophaties. 6.
Simulation/modeling of cardiomyophaties: experimental results and
problems. 7.
Cardiomyopathy associated with pulmonary circulation diseases (including
congenital heart diseases), differentiated approach to the problem. 8.
Disfunction and blocks of the sinoatrial nod in primary and secondary
cardiomyophaties; new program of electrophysiologic examination; results
achieved and therapeutic approaches (one-, two-and three- chamber
stimulators). 9.
HFS (short historic review), its modern classification: ·
acute heart failure (HF) ·
chronic HF ·
modern aspects of systolic and diastolic HF ·
differentited diagnosis – congestive HF and cardiomegaly ·
cardiomegaly in different pathologies and differentiated approach
to its management. ·
peripheral oedema, chest pain, tachicardia and bradicardia in
congestive HF – differentiated approach to their management. · neurocilculatory dystonia, syncope and cardiac shock (asystolia) in cardiomyopathies. (primary and secondary) – modern diagnostic techniques (echocardiography, Dopplerography, nuclear magnetic resonance, ventriculo – and coronarography, isotopic analysis, endomiocardial biopsy, electronic microscopy, immunology, serology, etc. analysis) 10.
HFS – acute viral myocarditis, primary and secondary dilatatory,
hypertrophic cardiomyopathy including subaortal stenosis and asymmetric
hypertrophic cardiomyopathy and restrictive cardiomyopathy, IHD,
hypertensive, etc. – modern aspects of management and therapy; 11.
Modern aspects of prevention and therapy of sudden death in high-risk
groups of patients and their relatives (both adohescents and grown- ups). 12.
Cardiomyopathies – neurologic and neuropsychologic symptoms and their
clinical aspects in subclinical and end-stage (IV class) HFS. 13. Pharmaceutic and intervntional therapy and surgical treatment of the primary and secondary cardiomyopathies – view into future.
|